Macrophages in Tumor Microenvironments and the Progression of Tumors
Open accessThe DOI matches its Crossref record; 120 of the 121 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
Macrophages are widely distributed innate immune cells that play indispensable roles in the innate and adaptive immune response to pathogens and in-tissue homeostasis. Macrophages can be activated by a variety of stimuli and polarized to functionally different phenotypes. Two distinct subsets of macrophages have been proposed, including classically activated (M1) and alternatively activated (M2) macrophages. M1 macrophages express a series of proinflammatory cytokines, chemokines, and effector molecules, such as IL-12, IL-23, TNF-α, iNOS and MHCI/II. In contrast, M2 macrophages express a wide array of anti-inflammatory molecules, such as IL-10, TGF-β, and arginase1. In most tumors, the infiltrated macrophages are considered to be of the M2 phenotype, which provides an immunosuppressive microenvironment for tumor growth. Furthermore, tumor-associated macrophages secrete many cytokines, chemokines, and proteases, which promote tumor angiogenesis, growth, metastasis, and immunosuppression. Recently, it was also found that tumor-associated macrophages interact with cancer stem cells. This interaction leads to tumorigenesis, metastasis, and drug resistance. So mediating macrophage to resist tumors is considered to be potential therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In contrast, many other neoplasms are associated with M2-like TAMs that secrete immunosuppressive cytokines that promote tumor growth and metastasis (8, 90).”
From Macrophage Cytokines: Involvement in Immunity and Infectious Diseases (2014) · cites this paper as [90]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Importantly, TAMs induce immunosuppression via release of IL-10 and TGF-β, both of which inhibit the development of cytotoxic T cells and NK cells, and may fuel the appearance of more M2-like TAMs at the tumor site (8, 67, 90).”
From Macrophage Cytokines: Involvement in Immunity and Infectious Diseases (2014) · cites this paper as [90]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In cancer, tumor-associated macrophages (TAMs) have been known to either promote or hinder neoplasia (8, 90).”
From Macrophage Cytokines: Involvement in Immunity and Infectious Diseases (2014) · cites this paper as [90]
In the citing paper
“In contrast, M2 macrophages (CD163) play an anti-inflammatory and pro-tumor role”
From Drug Resistance in Colorectal Cancer: From Mechanism to Clinic (2022) · cites this paper as [324]
In the citing paper
“TAMs often exhibit an “M2-like” phenotype [324].”
From Drug Resistance in Colorectal Cancer: From Mechanism to Clinic (2022) · cites this paper as [324]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Exploring the full spectrum of macrophage activation
Mosser, D. M., & Edwards, J. P. (2008) · Nature Reviews Immunology · doi:10.1038/nri2448 · Cited by 9,144 · cited 2×
“Finally, the monocytes migrate into different tissues and replenish the populations of long-lived tissue-specific macrophages, such as alveolar macrophages and kupffer cells [2, 3].”
BackgroundThe chemokine system in diverse forms of macrophage activation and polarization
MANTOVANI, A., SICA, A., SOZZANI, S., ALLAVENA, P., VECCHI, A., & LOCATI, M. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.09.015 · Cited by 6,534 · cited 4×
“Several studies reporting the use of “antimacrophage” approaches have primarily focused on counteracting monocyte chemokines and receptors as anticancer targets [10, 14, 36, 42].”
BackgroundInfluentialMANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528 · cited 1×
“, tumor necrosis factor-α (TNF-α)) [6] (Figure 1).”
Monocyte and macrophage heterogeneity
Gordon, S., & Taylor, P. R. (2005) · Nature Reviews Immunology · doi:10.1038/nri1733 · Cited by 5,190 · cited 1×
“Finally, the monocytes migrate into different tissues and replenish the populations of long-lived tissue-specific macrophages, such as alveolar macrophages and kupffer cells [2, 3].”
BackgroundNF-κB regulation in the immune system
Li, Q., & Verma, I. M. (2002) · Nature Reviews Immunology · doi:10.1038/nri910 · Cited by 4,007
Alternative Activation of Macrophages: An Immunologic Functional Perspective
Martinez, F. O., Helming, L., & Gordon, S. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132532 · Cited by 2,745 · cited 1×
“Finally, M2c macrophages are induced by IL-10, transforming growth factor-β (TGF-β), or glucocorticoids (GCs) [7] (Figure 1).”
BackgroundMacrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis
Condeelis, J., & Pollard, J. W. (2006) · Cell · doi:10.1016/j.cell.2006.01.007 · Cited by 2,695 · cited 7×
“M1 macrophages express a series of proinflammatory cytokines, chemokines, and effector molecules, such as IL-12, IL-23, TNF-α, iNOS and MHCI/II.”
BackgroundInfluentialInterleukin-17 Family Members and Inflammation
Kolls, J. K., & Lindén, A. (2004) · Immunity · doi:10.1016/j.immuni.2004.08.018 · Cited by 2,372 · cited 1×
“IL-23, which is also secreted by M1 macrophages, is associated with the development and expansion of Th17 cells, which can secrete high levels of IL-17 and contribute to inflammatory autoimmune pathologies [17, 18].”
BackgroundCancer and the chemokine network
Balkwill, F. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1388 · Cited by 2,343 · cited 1×
“Chemokines, such as CCL17 and CCL22, can prevent the infiltration of cytotoxic T-cells but promote that of Treg and Th2 cells [38, 94].”
Background
Research works printed but not linked: 12
- 2008, Journal of Immunology, 15, 3733
- 2002, American Journal of Pathology, 161, 947, 10.1016/s0002-9440(10)64255-1 · DOI · Paper page
- 2005, Oncology Reports, 14, 425
- 1996, Journal of Immunology, 156, 73
- 1997, Journal of Immunology, 159, 770
- 1995, Journal of Immunology, 154, 1280
- 2000, Cancer Research, 60, 2632
- 1999, International Journal of Cancer, 84, 539
- 1984, Annual Review of Immunology, 2, 283, 10.1146/annurev.iy.02.040184.001435 · doi:10.1146/annurev.iy.02.040184.001435 · Paper page
- 2003, Cancer Research, 63, 8360
- 1995, Cancer Research, 55, 1499
- 2003, Cancer Research, 63, 7853
Cited by
Items 201–300 of 1,000
Immunoproteasome dysfunction augments alternative polarization of alveolar macrophages
Chen, S., Kammerl, I. E., Vosyka, O., Baumann, T., Yu, Y., Wu, Y., Irmler, M., Overkleeft, H. S., Beckers, J., Eickelberg, O., et al. (2016) · Cell Death and Differentiation · doi:10.1038/cdd.2016.3 · Cited by 82
“[57] [58] [59] Under more severe inflammatory conditions of acute respiratory distress syndrome (ARDS) and acute lung injury, however, therapeutic application of steroids remains controversial as these drugs have no benefits and are associated with adverse outcome during late stages of ARDS. 59, 60 Alternative strateg…”
BackgroundTwo-photon luminescence properties of gold nanorods
Wang, T., Halaney, D. L., Ho, D. S., Feldman, M. D., & Milner, T. E. (2013) · Biomedical Optics Express · doi:10.1364/boe.4.000584 · Cited by 77
Razali, F. N., Sinniah, S. K., Hussin, H., Abidin, N. Z., & Shuib, A. S. (2016) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2016.06.079 · Cited by 73
Clinical Significance of Heme Oxygenase 1 in Tumor Progression
Nitti, M., Ivaldo, C., Traverso, N., & Furfaro, A. L. (2021) · Antioxidants · doi:10.3390/antiox10050789 · Cited by 76
Homma, Y., Taniguchi, K., Murakami, T., Nakagawa, K., Nakazawa, M., Matsuyama, R., Mori, R., Takeda, K., Ueda, M., Ichikawa, Y., et al. (2013) · Annals of Surgical Oncology · doi:10.1245/s10434-013-3390-y · Cited by 72
Tähtinen, S., Grönberg-Vähä-Koskela, S. A. M., Lumén, D., Merisalo-Soikkeli, M., Siurala, M., Airaksinen, A. J., Vähä-Koskela, M. J. V., & Hemminki, A. (2015) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-14-0220-t · Cited by 72
“Furthermore, the highly immunosuppressive TME typically renders infiltrating T cells incapable of killing their target (tumor) cells (8).”
BackgroundInfluentialEmerging therapeutic targets in metastatic progression: A focus on breast cancer
Li, Z., & Kang, Y. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.03.003 · Cited by 75
“…and MAMs are immunosuppressive and contribute to tumor progression via numerous macrophage-derived signaling factors, such as cytokines, growth factors, matrix metalloproteinases (MMPs), and hypoxia response proteins (Baay et al., 2011; Hao et al., 2012; Luo et al., 2006; Noy and Pollard, 2014).”
BackgroundThe Role of Semaphorin 4D in Bone Remodeling and Cancer Metastasis
Lontos, K., Adamik, J., Tsagianni, A., Galson, D. L., Chirgwin, J. M., & Suvannasankha, A. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00322 · Cited by 71
“org June 2018 | Volume 9 | Article 322 tumor progression (79).”
BackgroundBreast tumor and stromal cell responses to TGF-β and hypoxia in matrix deposition
Curran, C. S., & Keely, P. J. (2012) · Matrix Biology · doi:10.1016/j.matbio.2012.11.016 · Cited by 82
“As a result, macrophages at the tumor invasive front are thought to enhance tumorigenesis, angiogenesis, and the formation of metastatic disease (Hao et al., 2012).”
BackgroundImmunomodulation by Schwann cells in disease
Zhang, S. H., Shurin, G. V., Khosravi, H., Kazi, R., Kruglov, O., Shurin, M. R., & Bunimovich, Y. L. (2019) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-019-02424-7 · Cited by 70
Yu, J. E., Yeo, I. J., Son, D. J., Yun, J., Han, S., & Hong, J. T. (2021) · Molecular Oncology · doi:10.1002/1878-0261.13152 · Cited by 70
The Roles of Tumor-Associated Macrophages in Prostate Cancer
Han, C., Deng, Y., Xu, W., Liu, Z., Wang, T., Wang, S., Liu, J., & Liu, X. (2022) · Journal of Oncology · doi:10.1155/2022/8580043 · Cited by 74
“TME, as a host of a sophisticated signal network, provides a fertile ground conducive to tumor survival [5].”
BackgroundShao, S., Miao, H., & Ma, W. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1295684 · Cited by 70
Genetically Engineered Macrophages: A Potential Platform for Cancer Immunotherapy
Moyes, K. W., Lieberman, N. A. P., Kreuser, S. A., Chinn, H. K., Winter, C., Deutsch, G. H., Hoglund, V. J., Watson, R., & Crane, C. A. (2016) · Human Gene Therapy · doi:10.1089/hum.2016.060 · Cited by 71
“37 Additionally, tumor-derived factors such as TGF-b , M-CSF, IL-4, andIL-10mayalterthepolarizationoftheadoptively transferred macrophages, modifying their production of cytokines to promote the function of Tregs while inhibiting tumor-specific T cell respsonses.”
Wu, H., Zhang, X., Han, D., Cao, J., & Tian, J. (2020) · PeerJ · doi:10.7717/peerj.8721 · Cited by 74
Biomechanical Contributions to Macrophage Activation in the Tumor Microenvironment
Hoffmann, E. J., & Ponik, S. M. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00787 · Cited by 73
“Much work has been done to characterize soluble factors present in the TME that recruit and influence macrophage behavior (14), however less is known about how the mechanical properties of tumor ECM impact macrophage recruitment, activation, and cytokine secretion.”
BackgroundMacrophage Polarization and Its Role in Cancer
Smith, E. W. C. (2015) · Journal of Clinical & Cellular Immunology · doi:10.4172/2155-9899.1000338 · Cited by 92
“IL-4 is an important cytokine in the healing process because it contributes to the production of the extracellular matrix [15].”
BackgroundWeber, M., Möbius, P., Büttner-Herold, M. J., Amann, K., Preidl, R. H. M., Neukam, F. W., & Wehrhan, F. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.212 · Cited by 77
“…are associated with wound-healing, tissue remodelling, angiogenesis and tumour progression (Mantovani et al, 2007; Cao et al, 2011; Hirata et al, 2011; Kurahara et al, 2011; Murray and Wynn, 2011; Hao et al, 2012; Lan et al, 2012; Sica and Mantovani, 2012; Mantovani et al, 2013; Weber et al, 2014).”
BackgroundYamaguchi, T., Takizawa, F., Fischer, U., & Dijkstra, J. M. (2015) · Biology · doi:10.3390/biology4040814 · Cited by 75
“Very importantly, what emerges as a general impression from literature is that macrophage populations have less pronounced self-amplifying loops (although for an autocrine TNF-loop see [61] and [62], for an autocrine IL-10 loop see [63], and for an autocrine TGF-β loop see [64]) than known for TH/Treg polarizations, a…”
BackgroundInfluentialFrigerio, S., Lartey, D. A., D’Haens, G., & Grootjans, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222312739 · Cited by 69
Macrophage polarization differs between apical granulomas, radicular cysts, and dentigerous cysts
Weber, M., Schlittenbauer, T., Möbius, P., Büttner-Herold, M. J., Ries, J., Preidl, R. H. M., Geppert, C., Neukam, F. W., & Wehrhan, F. (2017) · Clinical Oral Investigations · doi:10.1007/s00784-017-2123-1 · Cited by 67
Koshikawa, N., Akimoto, M., Hayashi, J., Nagase, H., & Takenaga, K. (2017) · Scientific Reports · doi:10.1038/s41598-017-15592-2 · Cited by 67
Dzobo, K., & Dandara, C. (2020) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2020.0023 · Cited by 66
“Immune cells within the TME are mostly macrophages (Hao et al., 2012; Kim et al., 2012).”
Chen, J., Zhao, D., Zhang, L., Zhang, J., Xiao, Y., Wu, Q., Wang, Y., & Zhan, Q. (2022) · Cellular and Molecular Immunology · doi:10.1038/s41423-022-00903-z · Cited by 66
Zhou, L., Zhao, G., Liu, Q., Jiang, S., Wang, Y., & Zhang, D. (2015) · Journal of Inflammation · doi:10.1186/s12950-015-0053-8 · Cited by 69
“These results, consistent with the previous reports [26], indicated successful polarization of BMDMs to M1 and M2 subsets.”
Effect of M1–M2 Polarization on the Motility and Traction Stresses of Primary Human Macrophages
Hind, L. E., Lurier, E. B., Dembo, M., Spiller, K. L., & Hammer, D. A. (2016) · Cellular and Molecular Bioengineering · doi:10.1007/s12195-016-0435-x · Cited by 66
Lindsten, T., Hedbrant, A., Ramberg, A., Wijkander, J., Solterbeck, A., Eriksson, M., Delbro, D. S., & Erlandsson, A. (2017) · International Journal of Oncology · doi:10.3892/ijo.2017.3996 · Cited by 69
“They also constitute the most abundant immune cell present in the tumor stroma and display extensive diversity and plasticity (13-15).”
BackgroundRole of immune system in tumor progression and carcinogenesis
Upadhyay, S., Sharma, N., Gupta, K. B., & Dhiman, M. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26663 · Cited by 69
The complex roles of efferocytosis in cancer development, metastasis, and treatment
Tajbakhsh, A., Gheibi hayat, S. M., Movahedpour, A., Savardashtaki, A., Loveless, R., Barreto, G. E., Teng, Y., & Sahebkar, A. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111776 · Cited by 64
Chen, H., Li, M., Sanchez, E., Soof, C. M., Bujarski, S. E., Ng, N., Cao, J., Hekmati, T., Zahab, B., Nosrati, J. D., et al. (2019) · British Journal of Haematology · doi:10.1111/bjh.16158 · Cited by 76
“…promote tumour growth and metastasis through secretion of growth factors, vascular endothelial growth factor, matrix metalloproteinases and immunosuppressive cytokines/chemokines (Martinez et al, 2014, Asimakopoulos et al, 2013, Arango Duque & Descoteaux, 2014, Hao et al, 2012, Smith & Kang, 2013).”
BackgroundYuan, W., Zhang, Q., Gu, D., Lu, C., Dixit, D., Gimple, R. C., Gao, Y., Gao, J., Li, D., Shan, D., et al. (2023) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-22-3273 · Cited by 66
Is Adipose Tissue Inflammation the Culprit of Obesity‐Associated Comorbidities?
Turner, L., Wanasinghe, A. I., Brunori, P., & Santosa, S. (2025) · Obesity Reviews · doi:10.1111/obr.13956 · Cited by 68
“Although M2-like macrophages are typically known to have anti-inflammatory properties, their immunosuppressive role may promote tumor development and progression [240].”
The role played by the microenvironment in site-specific metastasis
Klein-Goldberg, A., Maman, S., & Witz, I. P. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.08.029 · Cited by 66
“cytes, and fibroblasts [48–55].”
Talekar, M., Trivedi, M. S., Shah, P., Ouyang, Q., Oka, A., Gandham, S. K., & Amiji, M. M. (2015) · Molecular Therapy · doi:10.1038/mt.2015.225 · Cited by 64
Comito, G., Segura, C. P., Taddei, M. L., Lanciotti, M., Serni, S., Morandi, A., Chiarugi, P., & Giannoni, E. (2016) · Oncotarget · doi:10.18632/oncotarget.9497 · Cited by 64
“In keeping, switch of M1 macrophages, endowed with immune stimulating and anti-tumour activities, towards the M2 phenotype is associated with a worse clinical prognosis and high grade of malignancy [11, 12].”
BackgroundDeshmukh, S. K., Srivastava, S. K., Tyagi, N., Ahmad, A., Singh, A. P., AL-Ghadhban, A., Dyess, D. L., Carter, J. E., Dugger, K. J., & Singh, S. (2017) · Carcinogenesis · doi:10.1093/carcin/bgx037 · Cited by 66
Zhao, X., Li, J., Liu, Y., Wu, D., Cai, P., & Pan, Y. (2017) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2017.05.014 · Cited by 64
“Immunomodulatory activity of BTp1 Macrophages play indispensable roles in the innate and adaptive immune response to pathogens and in-tissue homeostasis (Hao et al., 2012).”
BackgroundZhao, P., Gao, D., Wang, Q., Song, B., Shao, Q., Sun, J., Ji, C., Li, X., Li, P., & Qu, X. (2014) · Cellular and Molecular Immunology · doi:10.1038/cmi.2014.108 · Cited by 63
Crosstalk between M2 macrophages and glioma stem cells
Nusblat, L. M., Carroll, M. J., & Roth, C. M. (2017) · Cellular Oncology · doi:10.1007/s13402-017-0337-5 · Cited by 64
Pancreatic Cancer and Cellular Senescence: Tumor Microenvironment under the Spotlight
Cortesi, M., Zanoni, M., Pirini, F., Tumedei, M. M., Ravaioli, S., Rapposelli, I. G., Frassineti, G. L., & Bravaccini, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010254 · Cited by 65
“The immunosuppressive properties of TAMs are mainly related to the secretion of particular cytokines, chemokines, and enzymes [73]; to their ability to modulate T cell metabolism through the expression of Arg1 in a manner similar to that”
BackgroundPatel, R. K., Rahman, S., Schwantes, I. R., Bartlett, A. Q., Eil, R. L., Farsad, K., Fowler, K. J., Goodyear, S. M., Hansen, L., Kardosh, A., et al. (2023) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2023.08.012 · Cited by 64
“51 Although the gut-liver-Kupffer cell interaction is complex and incompletely understood, there is evidence to suggest that Kupffer cells have inhibitory and stimulatory roles in tumor development.”
BackgroundAlves, A. M., Diel, L. F., Ramos, G. D. O., Pinto, A. F. M., Bernardi, L., Yates, J. R., & Lamers, M. L. (2020) · Oral Oncology · doi:10.1016/j.oraloncology.2020.105038 · Cited by 68
Receptor Activator of NF-κB Ligand Promotes the Production of CCL17 from RANK+ M2 Macrophages
Fujimura, T., Kambayashi, Y., Furudate, S., Asano, M., Kakizaki, A., & Aiba, S. (2015) · Journal of Investigative Dermatology · doi:10.1038/jid.2015.209 · Cited by 66
Sugihara, H., Ishimoto, T., Watanabe, M., Sawayama, H., Iwatsuki, M., Baba, Y., Komohara, Y., Takeya, M., & Baba, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081839 · Cited by 64
“different functional roles in the tumor microenvironment [11,12].”
BackgroundInterleukin-10 Induces Both Plasma Cell Proliferation and Angiogenesis in Multiple Myeloma
Alexandrakis, M. G., Goulidaki, N., Pappa, C. A., Boula, A., Psarakis, F. E., Neonakis, I., & Tsirakis, G. (2015) · Pathology & Oncology Research · doi:10.1007/s12253-015-9921-z · Cited by 66
“biological functions, such as neovascularization [19].”
Anand, S., Chan, T. A.-T., Hasan, T. G., & Maytin, E. V. (2021) · Pharmaceuticals · doi:10.3390/ph14050447 · Cited by 69
Li, C., Maishi, N., Annan, D. A., Young, M. F., Morimoto, H., Morimoto, M., Nam, J.-M., Hida, Y., & Hida, K. (2021) · Breast Cancer Research · doi:10.1186/s13058-021-01423-w · Cited by 65
“M2-like macrophages play a critical role in promoting the formation of an abnormal tumor vascular network and subsequent tumor progression and invasion [54].”
BackgroundElsum, I. A., Yates, L. L., Pearson, H. B., Phesse, T. J., Long, F., O'Donoghue, R., Ernst, M., Cullinane, C., & Humbert, P. O. (2014) · Oncogene · doi:10.1038/onc.2013.498 · Cited by 60
Immunometabolism in biofilm infection: lessons from cancer
Mirzaei, R., Sabokroo, N., Ahmadyousefi, Y., Motamedi, H., & Karampoor, S. (2022) · Molecular Medicine · doi:10.1186/s10020-022-00435-2 · Cited by 63
Ghosh, S., Mukherjee, S., Choudhury, S., Gupta, P., Adhikary, A., Baral, R., & Chattopadhyay, S. (2015) · Cellular Signalling · doi:10.1016/j.cellsig.2015.03.013 · Cited by 63
“promote antitumor immune responses whereas tumor-associated macrophages (TAMs) generally exhibit an altered M2-like tumor-promoting phenotype [42-45].”
BackgroundThe Impact of the Tumor Microenvironment on the Properties of Glioma Stem-Like Cells
Audia, A., Conroy, S., Glaß, R., & Bhat, K. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00143 · Cited by 62
“While one study showed a lack of phagocytic activity of these cell types (72), and their secreted cytokines, such us IL-6 and IL-10, can promote cancer cell proliferation (73), other studies have shown that factors secreted by glioma cells can promote phagocytosis, and proliferation of microglial cells (74).”
Guo, L., Zhang, Y., Wei, R., Zhang, X., Wang, C., & Feng, M. (2020) · Theranostics · doi:10.7150/thno.45528 · Cited by 61
“Therefore, ApB and Exo surface are inevitably incorporated with varying degrees of certain membrane compositions, which, in combination with CCR2 by M1 macrophages, may recognize and interact with target cells [45].”
BackgroundMetabolic Homeostasis‐Regulated Nanoparticles for Antibody‐Independent Cancer Radio‐Immunotherapy
Shen, W., Liu, T., Pei, P., Li, J., Yang, S., Zhang, Y., Zhou, H., Hu, L. T., & Yang, K. (2022) · Advanced Materials · doi:10.1002/adma.202207343 · Cited by 61
Self-citationHuang, Y., Ruan, Y., Ma, Y., Chen, D., Zhang, T., Fan, S., Lin, W., Huang, Y., Lü, H., Xu, J.-F., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1128840 · Cited by 68
“Moreover, M1 can directly engulf tumor cells (65) or target tumor cells by releasing pro-inflammatory cytokines (66), and can also act as APC to activate T cells, thus enhancing adaptive anti-tumor immunity (67, 68).”
BackgroundSharma, P., & Otto, M. (2023) · Bioactive Materials · doi:10.1016/j.bioactmat.2023.08.022 · Cited by 66
Targeted therapy of cancer stem cells: inhibition of mTOR in pre-clinical and clinical research
Son, B., Lee, W., Kim, H., Shin, H., & Park, H. H. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-07077-8 · Cited by 60
“Consequently, the anti-in fl ammatory environment induced by these M2 macrophages contributes to therapeutics resistance [263, 279 – 281].”
BackgroundChen, Y., Bi, L., Luo, H., Jiang, Y., Chen, F., Wang, Y., Wei, G., & Chen, W. (2018) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2018.12.003 · Cited by 61
Zhang, J., Qu, C., Li, T., Cui, W., Wang, X., & Du, J. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.008795 · Cited by 69
“M2 macrophages increase the expression of anti-inflammatory cytokines and inactivate Th1 cells (11).”
BackgroundShen, H., Liu, J., Chen, S., Ma, X., Ying, Y., Li, J., Wang, W., Wang, X., & Xie, L. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.657318 · Cited by 70
Nanomedicine-based cancer immunotherapies developed by reprogramming tumor-associated macrophages
Li, X., Guo, X., Ling, J., Tang, Z., Huang, G., He, L., & Chen, T. (2021) · Nanoscale · doi:10.1039/d0nr08050k · Cited by 61
The roles of FOXM1 in pancreatic stem cells and carcinogenesis
Quan, M., Wang, P., Cui, J., Gao, Y., & Xie, K. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-159 · Cited by 62
“Evidently, the infiltrated macrophages in most tumors are M2 phenotype, which provides an immunosuppressive microenvironment for tumor progression [138].”
BackgroundGao, J., Wang, D., Liu, D., Liu, M., Ge, Y., Jiang, M., Liu, Y., & Zheng, D. (2015) · Molecular Biology of the Cell · doi:10.1091/mbc.e15-04-0209 · Cited by 60
“Tumor-associated macrophages (TAMs), which are a major component of the leukocytic infiltrate of tumors, usually display an immunosuppressive phenotype and protumorigenic properties, features that are typically associated with poor prognosis (Qian and Pollard, 2010; Hao et al., 2012).”
Alterations of tumor microenvironment by carbon monoxide impedes lung cancer growth
Nemeth, Z., Csizmadia, E., Vikstrom, L., Li, M., Bisht, K., Feizi, A., Otterbein, S., Zuckerbraun, B., Costa, D. B., Pandolfi, P. P., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8081 · Cited by 57
“TAMs are polarized towards a pro-angiogenic, IL-10 producing M2 phenotype and are associated with poor prognosis [11, 12].”
BackgroundTGF-β Sustains Tumor Progression through Biochemical and Mechanical Signal Transduction
O’Brien, R. L. F., Nixon, D. F., Brantner, C. A., Popratiloff, A. S., & Uíttenbogaart, C. H. (2018) · Cancers · doi:10.3390/cancers10060199 · Cited by 61
“Tumor-associated macrophages often exhibit an immunosuppressive M2 phenotype by expressing interleukin 10 (IL-10), arginase-1, and TGF-β1 [32].”
BackgroundYang, S., Zhou, Y., Sun, Y., Wang, Y., Yin, J., Huang, Y., Zhang, J., He, A., Han, K., Zhang, H., et al. (2018) · Journal of Molecular Medicine · doi:10.1007/s00109-018-1711-0 · Cited by 58
Self-citationImmunomodulatory aspects in the progression and treatment of oral malignancy
Kondoh, N., Mizuno‐Kamiya, M., Umemura, N., Takayama, E., Kawaki, H., Mitsudo, K., Muramatsu, Y., & Sumitomo, S. (2019) · Japanese Dental Science Review · doi:10.1016/j.jdsr.2019.09.001 · Cited by 61
“The mechanism by which OSCCs diferentially utilize immune modulation involving CAFs, MDSCs and everal other factors is not fully understood.”
BackgroundInfluentialAquaporin 1 alleviates acute kidney injury via PI3K-mediated macrophage M2 polarization
Liu, C., Li, B., Tang, K., Dong, X., Xue, L., Su, G., & Jin, Y. (2020) · Inflammation Research · doi:10.1007/s00011-020-01334-0 · Cited by 58
“M2 macrophages play different roles in different diseases, for instance, it has been shown that in allergic diseases caused by parasites, M2 macrophages promote inflammation and aggravate injury [39], whereas M2 macrophages have been shown to play a role in promoting tumor growth [40], therefore, the relationship betw…”
BackgroundBacillus Calmette-Guerin (BCG): Its fight against pathogens and cancer
Sfakianos, J. P., Salomé, B., Daza, J., Farkas, A. M., Bhardwaj, N., & Horowitz, A. (2020) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2020.09.031 · Cited by 60
MicroRNAs in the Diagnosis and Treatment of Cancer
Mansoori, B., Mohammadi, A., Shirjang, S., & Baradaran, B. (2017) · Immunological Investigations · doi:10.1080/08820139.2017.1377407 · Cited by 58
Gharib, E., & Robichaud, G. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179463 · Cited by 65
Hollander, L. L., Guo, X., Velázquez, H., Chang, J. J., Safirstein, R. L., Kluger, H. M., Cha, C. H., & Désir, G. V. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-1524 · Cited by 60
“Experimental data indicate that alternatively activated macrophages (M2-like, CD163+) recruited into the tumors suppress the immune response against the tumor, increase angiogenesis, and facilitate tumor cell migration, invasion and dissemination (33-35).”
BackgroundOptimized Near-IR Fluorescent Agents for in Vivo Imaging of Btk Expression
Kim, E., Yang, K. S., Kohler, R. H., Dubach, J. M., Mikula, H., & Weissleder, R. (2015) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.5b00152 · Cited by 57
“13, 14 Given the importance of macrophage subsets in tumor development and progression, 15, 16 as well as in other chronic diseases, 17 it appears that Btk inhibition may offer a new therapeutic approach in modulating macrophage populations.”
BackgroundThe emerging landscape of circular RNAs in immunity: breakthroughs and challenges
Li, Z., Cheng, Y., Wu, F., Wu, L., Cao, H., Wang, Q., & Tang, W. (2020) · Biomarker Research · doi:10.1186/s40364-020-00204-5 · Cited by 61
Deng, Y., Xie, J., Luo, Z., Li, S., & Zhao, J. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.09.199 · Cited by 56
Park, J. V., Chandra, R., Cai, L., Ganguly, D., Li, H., Toombs, J. E., Girard, L., Brekken, R. A., & Minna, J. D. (2022) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2022.06.011 · Cited by 57
Mechanisms shared between cancer, heart failure, and targeted anti-cancer therapies
de Wit, S., Glen, C., de Boer, R. A., & Lang, N. N. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvac132 · Cited by 59
Cancer immunotherapy via synergistic coactivation of myeloid receptors CD40 and Dectin-1
Wattenberg, M. M., Coho, H., Herrera, V. M., Graham, K. L., Stone, M. L., Xue, Y., Chang, R. B., Cassella, C. R., Liu, M., Choi-Bose, S., et al. (2023) · Science Immunology · doi:10.1126/sciimmunol.adj5097 · Cited by 57
“CD206 + marks a prototypical immunosuppressive macrophage subset ( 32 ), suggesting that treatment shifted tumor-associated macrophages (TAMs) away from a tumor-promoting state.”
BackgroundTargeting Macrophage Polarization for Reinstating Homeostasis following Tissue Damage
Du, Q., Dickinson, A., Nakuleswaran, P., Maghami, S., Alagoda, S., Hook, A. L., & Ghaemmaghami, A. M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137278 · Cited by 59
“M2c macrophages express IL-10, TGF-β , MR, and Arg-1, and promote the production of growth factors, polyamines, and collagen, which are beneficial to tissue repair and regeneration [18,201,202].”
BackgroundCardoso, A., Gonçalves, R., Antunes, J., Pinto, M., Pinto, A., Castro, F., Monteiro, C., Barbosa, M., & Oliveira, M. (2015) · Acta Biomaterialia · doi:10.1016/j.actbio.2015.05.022 · Cited by 53
“M2 macrophages are efficient stimulators of cancer cell invasion [47].”
BackgroundRuffino, J. S., Davies, N. A., Morris, K., Ludgate, M., Zhang, L., Webb, R., & Thomas, A. W. (2016) · European Journal of Applied Physiology · doi:10.1007/s00421-016-3414-y · Cited by 65
“Interestingly, the profile of polarisation markers expressed by monocytes following exercise training in the current study is representative of a specific M2 macrophage subtype; the ‘M2b’ macrophage subset, which are said to produce M1-associated cytokines (including TNFα) but also high levels of IL-10, causing M2b ce…”
BackgroundSilva, I., Chammas, R. J., Lepique, A. P., & Jancar, S. (2017) · Oncogenesis · doi:10.1038/oncsis.2016.90 · Cited by 57
The Role of TAMs in Tumor Microenvironment and New Research Progress
Feng, Y., Ye, Z., Song, F., He, Y., & Liu, J. (2022) · Stem Cells International · doi:10.1155/2022/5775696 · Cited by 62
“With low expression of IL-12 and high expression of IL-10, its tumor-killing activity is low, and TAM is closer to the functional phenotype of M2 macrophages [9, 10].”
BackgroundRetractedImmunomodulatory effects of curcumin on macrophage polarization in rheumatoid arthritis
Deng, T.-T., Xu, J.-H., Wang, Q., Wang, X., Jiao, Y., Cao, X., Geng, Q., Zhang, M., Zhao, L., & Xiao, C. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1369337 · Cited by 47
“According totheirdifferentstimuliandfunctions,M2macrophages are further categorized into four subsets: M2a, M2b, M2c and M2d macrophages (Hao et al., 2012).”
BackgroundThe tumour microenvironment of pituitary neuroendocrine tumours
Marques, P., Grossman, A. B., & Korbonits, M. (2020) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2020.100852 · Cited by 57
Sologuren, I., Rodríguez‐Gallego, C., & Lara, P. C. (2014) · Translational Cancer Research · doi:10.21037/2091 · Cited by 65
“TNF-α and IL-1β initiate the immune system activity, whereas other cytokines such as TGF-β, IL-10 and IL-4 may suppress the immune response (21).”
BackgroundInfluentialGPCR Signaling Mediates Tumor Metastasis via PI3Kβ
Khalil, B. D., Hsueh, C., Cao, Y., Saab, W. F. A., Wang, Y., Condeelis, J. S., Bresnick, A. R., & Backer, J. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-1675 · Cited by 59
Self-citationChoi, K., Komurov, K., Fletcher, J. S., Jousma, E., Cancelas, J. A., Wu, J., & Ratner, N. (2017) · Scientific Reports · doi:10.1038/srep43315 · Cited by 55
Huang, E., Chang, J., Chen, H., Hsu, C.-Y., Hsu, H., & Wu, K. (2018) · BMC Cancer · doi:10.1186/s12885-018-4254-4 · Cited by 54
“Macrophages are the major immune cells in cancer microenvironments [25].”
Zhang, Y., Feng, J., Fu, H., Liu, C., Yu, Z., Sun, Y., She, X., Li, P., Zhao, C., Liu, Y., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01557 · Cited by 55
“M1 macrophages represent tumor-suppressive macrophages and participate in polarized T helper 1 (Th1) responses, via the production of the pro-inflammatory mediators TNF-α, IL-1β, and IL-6 (10).”
BackgroundInfluentialYang, K., Gao, J., & Luo, M. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s158619 · Cited by 58
“For example, IL-4 and IL-13, pro-inflammatory cytokines, are known to support M2 macrophage polarization, whereas TGF-β recruits and retains macrophages at the tumor site and promotes tumor angiogenesis.(16,17) Besides, a disturbance in central carbon metabolism indicates an increased carbon flux through the pentose p…”
Regulatory Role of Quiescence in the Biological Function of Cancer Stem Cells
Lee, S. H., Reed-Newman, T. C., Anant, S., & Ramasamy, T. S. (2020) · Stem Cell Reviews and Reports · doi:10.1007/s12015-020-10031-8 · Cited by 56
Lima, B. V., Oliveira, M. J., Barbosa, M. A., Gonçalves, R. M., & Castro, F. (2021) · Biomaterials Science · doi:10.1039/d0bm01984d · Cited by 53
The impact of macrophage-cancer cell interaction on the efficacy of photodynamic therapy
Korbelik, M., & Hamblin, M. R. (2015) · Photochemical & Photobiological Sciences · doi:10.1039/c4pp00451e · Cited by 52
Ambrožová, G., Martiskova, H., Koudelka, A., Ravekes, T., Rudolph, T. K., Klinke, A., Rudolph, V., Freeman, B. Α., Woodcock, S. R., Kubala, L., et al. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.11.026 · Cited by 52
“Despite considerable insight into the mechanisms of macrophage involvement in different pathologies [7-11], only limited therapeutic strategies that modulate macrophage function are employed in clinical practice.”
BackgroundYan, H., Dong, M., Liu, X., Shen, Q., He, D., Huang, X., Zhang, E., Lin, X., Chen, Q., Guo, X., et al. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.01.012 · Cited by 52
Li, C., Wang, L., Zhao, J., Wei, Y., Zhai, S., Tan, M., Guan, K., Huang, Z., & Chen, C. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.154284 · Cited by 55
Würdinger, T., Deumelandt, K., van der Vliet, H. J., Wesseling, P., & de Gruijl, T. D. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.10.003 · Cited by 58
“by an incompetence to induce an anti-tumour T-cell response and by immunosuppressive features [88,89].”
BackgroundSingh, S., Awuah, D., Rostam, H. M., Emes, R. D., Kandola, N. K., Onion, D., Htwe, S. S., Rajchagool, B., Cha, B.-H., Kim, D., et al. (2017) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.7b00104 · Cited by 51
TGF-β Inhibitors in Metastatic Pancreatic Ductal Adenocarcinoma
Alvarez, M. A., Freitas, J. P., Hussain, S. M., & Glazer, E. S. (2019) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-018-00195-5 · Cited by 56
Different properties of skin of different body sites: The root of keloid formation?
Butzelaar, L., Niessen, F. B., Talhout, W., Schooneman, D. P. M., Ulrich, M. M. W., Beelen, R. H. J., & van der Molen, A. B. M. (2017) · Wound Repair and Regeneration · doi:10.1111/wrr.12574 · Cited by 52
“In addition, a shift toward M2 phenotype is associated with tumor progression.(44) Consequently, the inhibited inflammatory milieu (skewed toward M2) in keloid predilection areas could facilitate migration of keloid fibroblasts and, therefore, keloid outgrowth.”
Background
Metadata
- Authors
- Hao, N.-B., Lü, M.-H., Fan, Y.-H., Cao, Y.-L., Zhang, Z.-R., & Yang, S.-M.
- Affiliations
- Army Medical University (CN)
- Department of Gastroenterology, Xinqiao Hospital, Third Military Medical University, Chongqing 400037, China
- Biomedical Analysis Center, Third Military Medical University, Chongqing 40038, China
- Corresponding author
- Zhang, Zhi-Ren
- Venue
- Clinical and Developmental Immunology
- Publisher
- Wiley
- Published
- 2012
- Volume
- 2012
- Pages
- 1-11
- ISSN
- 1740-2522 (ISSN-L)
- 1740-2530
- PMC
- PMC3385963
- OpenAlex
- W2106027870
- Cited by
- 1,003
- References
- 121
- Citations by year
- 2026: 28 · 2025: 52 · 2024: 79 · 2023: 75 · 2022: 81 · 2021: 109 · 2020: 86 · 2019: 60 · 2018: 65 · 2017: 70 · 2016: 73 · 2015: 85 · 2014: 69 · 2013: 68 · 2012: 2
- FWCI
- 6.61
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Clinical and Developmental Immunology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Natural Science Foundation of China (31170851, 2010CB529406, 2009BA5045)
- National Basic Research Program of China (31170851, 2010CB529406, 2009BA5045)
- Chongqing Science Fund for Distinguished Young Scholars (31170851, 2010CB529406, 2009BA5045)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Stress, Anesthesia, and Immune Response
- Keywords
- tumor-associated macrophages, tumor microenvironment, macrophage polarization, M1 macrophages, M2 macrophages, immunosuppression, tumor angiogenesis, metastasis, cancer stem cells, drug resistance, macrophage-targeted therapy
- MeSH terms
- Animals, Humans, Macrophages, Neoplasms, Disease Progression, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.